Article Text

Download PDFPDF
CASE REPORT
Cocaine-induced very late stent thrombosis
  1. Priyank Shah1,
  2. Rahul Vasudev2,
  3. Ahmad Hisham Abuarqoub3,
  4. Fayez Shamoon1
  1. 1Department of Cardiology, New York Medical College at St Joseph's Regional Medical Center, Paterson, New Jersey, USA
  2. 2Department of Internal Medicine, New York Medical College at St Joseph's Regional Medical Center, Paterson, New Jersey, USA
  3. 3Department of Internal Medicine, Saint Michael's Medical Center, Newark, New Jersey, USA
  1. Correspondence to Dr Rahul Vasudev, drrahulvasudev{at}gmail.com

Summary

Cocaine misuse is a known cause of acute coronary syndrome (ACS). Management of these patients has always been a challenge due to medication compliance and eventual risk of stent thrombosis. However, even cocaine misusers who are compliant with dual antiplatelet therapy have been reported to have stent thrombosis. All cases of cocaine-induced stent thrombosis reported in the literature have occurred within first year of stent placement (acute, subacute or late). We report a first case of very late stent thrombosis in a 54-year-old active cocaine misuser who presented with ST segment elevation myocardial infarction, which was successfully managed with percutaneous transluminal coronary angioplasty. A review of all the reported cases of cocaine-induced stent thrombosis is also discussed. Given the high mortality associated with stent thrombosis, treatment option for cocaine misusers presenting with ACS should be conservative when possible. If percutaneous coronary intervention is needed, bare metal stent should be preferred.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors PS contributes to idea concept and design. RV was involved in reporting concept and design. AHA was involved in data acquisition and interpretation. FS was involved in editing and analysis of the final report. All authors have contributed to the manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.